Talk:Interleukin-10 receptor

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Wiki Education Foundation-supported course assignment[edit]

This article was the subject of a Wiki Education Foundation-supported course assignment, between 23 August 2021 and 10 December 2021. Further details are available on the course page. Student editor(s): SimonsEM.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 00:37, 17 January 2022 (UTC)[reply]

Requested move[edit]

The following discussion is an archived discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review. No further edits should be made to this section.

The result of the move request was: not moved. The brief rationale given bears no obvious relationship to article naming policy, and there is no support. Andrewa (talk) 18:19, 23 May 2013 (UTC)[reply]

– Usage, accuracy and style. See also Talk:Interferon, alpha 1 and Talk:Interferon-γ Receptor-1 and 2 Mutations. NyascaB (talk) 08:55, 15 May 2013 (UTC)[reply]

Strong oppose – the current article names are based on the recommended UniProt protein names (see for example P01562 and P14784. Boghog (talk) 20:07, 15 May 2013 (UTC)[reply]
Oppose lacking any explanation of the rationale. It seems to me that "Usage, accuracy and style" would require a hyphen in the compound modifying receptor, even if those compounds might lack the hyphen when standing alone as nouns. But in sources I see that even in the noun case they are hyphenated by many, so it's not clear what usage, what accuracy, and what style nom has in mind. Dicklyon (talk) 06:40, 17 May 2013 (UTC)[reply]

The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page or in a move review. No further edits should be made to this section.

Dear Wiki Community, I'd like to propose this outline of edits and content to add to the "Interleukin-8 receptor" page, please let me know what you think! Tnzhou

Possible edits: -Protein Profile and Introduction: Include a computer-generated image of protein, protein size (kD), subunits, active site(s), binding site(s), ligands, protein type, where it can be found and on which cells it can be found -Section: "Ligands and Binding Specificity"-- CXCR binds with high affinity to Interleukin 8, but is also respondent to other ligands; elaboration on biochemistry of binding and effects of binding of ligands to CXCR, affinity for other cytokines aside from CXC -Section: "Pathways in Immunity and Inflammation"--elaboration on how CXCR recruits neutrophils via chemokine interactions to induce inflammatory response in various types of tissue. Discuss the receptors role as a kinase and what it does to activate other kinases -Section: "Pathways in Cancer and Angiogenesis" -- CXCR is known to be in involved with the pathogenesis and angiogenesis of particular cancers and tumors alongside its corresponding ligand, CXC (Interleukin 8). Discussion about the expression of CXCR in tumors as well as its role in inducing the development of blood vessels -Section: "Similarities and Differences between Interleukin-8-Receptor (Alpha) and Interleukin-8-Receptor (Beta)" -- discussion of each receptors functions, ligands, and the similarities and differences between the two receptors. Discussion about independent function and differing affinities for ligands.